We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00101231
Recruitment Status : Terminated
First Posted : January 10, 2005
Last Update Posted : June 4, 2013
Information provided by (Responsible Party):
National Cancer Institute (NCI)